Philadelphia, PA · Compounded Semaglutide
Compounded Semaglutide in Philadelphia, PA — Telehealth Access from $86/mo
Ozari serves patients in Philadelphia and across Pennsylvania through licensed telehealth clinicians. Philadelphia is Pennsylvania's largest city and a world-class medical center, home to Penn Medicine, Jefferson Health, and Temple University Hospital among dozens of major health systems
Prescriptions are filled by Ozari's named 503A partners — Hallandale Pharmacy (PCAB-accredited) and VialsRx (USP 797 sterile compounding) — and shipped directly to your Pennsylvania address.
Pennsylvania's telehealth parity laws guarantee Philadelphia residents full access to licensed GLP-1 prescriptions online, with insurance protections equivalent to traditional in-person care
Compounded semaglutide and tirzepatide are prescribed for documented individual patient need by licensed physicians and prepared by licensed U.S. compounding pharmacies. Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality.
Start Online Visit
Quick Answer
Compounded semaglutide is a pharmacy-prepared prescription, not an FDA-approved Wegovy product. Philadelphia residents can complete Ozari's online intake, receive physician review, and have medication shipped home with plans from $86/month on the Starter tier when clinically appropriate.
Published pricing for Philadelphia patients
All plans below are sourced from Ozari's current treatment pricing. No insurance required.
Tap to switch plan type
$257 billed every 3 months
Save $268
Pricing last verified: July 28, 2026
Branded comparison: Retail pharmacy cash pricing for branded Wegovy often exceeds $1,000 per month without manufacturer programs. Through NovoCare self-pay, Wegovy is listed at $199 per month for the first two qualifying fills, then $349 per month for standard doses under current manufacturer terms — verify NovoCare before comparing.
Telehealth access for Pennsylvania patients
Pennsylvania enacted a telehealth parity law (Act 94) in 2022 requiring commercial insurers to cover telehealth services equivalently to in-person care. The Pennsylvania State Board of Medicine permits physicians to prescribe to patients they've evaluated via synchronous video, without requiring a prior in-person examination. Pennsylvania's large and diverse population — from Philadelphia and Pittsburgh to rural Appalachian communities — benefits substantially from telehealth's ability to extend specialist access to every corner of the state.
How Ozari's process works
A physician-led workflow for Philadelphia residents who want transparent pricing and named pharmacy partners.
Step 1
Complete your online intake
Answer structured health questions from anywhere in Pennsylvania. Most patients finish in under 10 minutes.
Step 2
Physician review and eligibility decision
A licensed clinician reviews your history, contraindications, and goals before any prescription is written.
Step 3
Pharmacy fulfillment and home delivery
If prescribed, your order is prepared by a licensed 503A partner pharmacy and shipped to your Pennsylvania address with cold-chain packaging when required.
Step 4
Ongoing clinical support
Message your care team for titration questions, side effects, and refills instead of navigating clinic phone trees.
Named pharmacy partners
Ozari does not sell semaglutide from inventory. Every order is patient-specific, written by a licensed prescriber, and prepared by either Hallandale Pharmacy — a PCAB-accredited 503A facility in Fort Lauderdale, Florida — or VialsRx, a U.S.-licensed 503A pharmacy compounding under USP 797 standards. Your shipment label identifies the dispensing pharmacy. Ozari Health holds LegitScript certification for its telehealth platform, which third parties can verify independently.
Hallandale Pharmacy
PCAB-accredited 503A compounding pharmacy in Fort Lauderdale, Florida
VialsRx
U.S.-licensed 503A compounding pharmacy operating under USP 797 sterile compounding standards
Frequently asked questions
Common questions from Philadelphia patients considering compounded semaglutide.
Compounded semaglutide is prepared by a licensed 503A pharmacy for an individual prescription. Branded Wegovy is an FDA-approved finished product with a full FDA review of safety, efficacy, and manufacturing. Compounded versions are not FDA-approved, not generic equivalents, and are prescribed only when a licensed clinician determines they are appropriate for your history.
Ozari publishes flat-rate plans for Philadelphia, Pennsylvania: $86/month equivalent on the 3-Month Starter Plan ($257 every 3 months, first-time GLP-1 users), $145/month on Quarterly ($435 every 3 months), or $175/month month-to-month. Free shipping is included; no insurance is required.
Safety depends on appropriate prescribing, pharmacy standards, and follow-up care — not price alone. Ozari uses named 503A partners (Hallandale Pharmacy, PCAB-accredited; VialsRx, USP 797) and a LegitScript-certified telehealth platform. Compounded products are still not FDA-approved finished drugs, so your clinician must review contraindications before treatment.
You complete a secure online intake, a licensed clinician reviews your record, and a prescription is sent to a 503A partner pharmacy only if treatment is medically appropriate. Medication ships to your Philadelphia, Pennsylvania address. There is no checkout without clinician review.
In STEP 1 (NEJM 2021), FDA-approved semaglutide 2.4 mg with lifestyle support produced a mean 14.9% body weight reduction at 68 weeks versus 2.4% with placebo. Published trial averages are not guarantees for compounded products or for any individual patient.
Pennsylvania enacted a telehealth parity law (Act 94) in 2022 requiring commercial insurers to cover telehealth services equivalently to in-person care. The Pennsylvania State Board of Medicine permits physicians to prescribe to patients they've evaluated via synchronous video, without requiring a prior in-person examination.
Ozari routes prescriptions to Hallandale Pharmacy (PCAB-accredited 503A, Fort Lauderdale, FL) or VialsRx (U.S.-licensed 503A, USP 797). Your vial label and patient materials identify the dispensing pharmacy for that shipment.
Yes. Eligible Philadelphia, Pennsylvania patients receive free expedited shipping to residential or business addresses statewide once a prescription is approved and filled. Cold-chain packaging is used when required for medication stability in transit.
Ready to start in Philadelphia?
Complete your intake online. A licensed clinician reviews your information before any prescription is written.
Start Online Visit